Skip to content

13F-HR filed by Lepercq De Neuflize Asset Management LLC

Lepercq De Neuflize Asset Management LLC filed this 13F-HR for the quarter ended 2025-03-31, filed 2025-05-13, with 14 holding rows worth $103,303,581.

Accession
0001420506-25-000994
Filed
2025-05-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2025

A holdings report, 14 entries on the cover page, a total value of $103,303,581 stated on the cover page (in dollars after the unit check, H1), rows summing to $103,303,581 with VALUE read as dollars as filed, 13F file number 028-25047. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS115,245$64,466,901dollars as filed
ISHARES TR464287465MSCI EAFE ETF466,000$38,086,180dollars as filed
LIFECOREBIOMEDICALINC514766104STOK19,700$138,688dollars as filed
XYLO TECHNOLOGIES LTD - SPON ADR58471G508COM26,059$127,950dollars as filed
WETOUCH TECHNOLOGY INC961881208COM NEW67,954$98,533dollars as filed
CLARUS CORP NEW18270P109COM22,200$83,250dollars as filed
PRESIDIO PPTY TR INC74102L303COM CL A134,125$77,122dollars as filed
Enzo Biochem Inc294100102Common Stock156,303$57,832dollars as filed
ESSA PHARMA INC29668H708COM NEW31,700$50,086dollars as filed
AN2 THERAPEUTICS INC037326105COM23,234$31,598dollars as filed
LAVA THERAPEUTICS NVN51517105SHS23,000$29,210dollars as filed
BARNWELL INDS INC068221100COM15,000$24,300dollars as filed
DESWELL INDS INC250639101COM10,000$23,550dollars as filed
LGL GROUP INC50186A132*W EXP 11/16/20226,200$8,381dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-25-000994this filing2025-05-13acceptance time not in the bulk data set